Skip to content

Complex Treatment of a Chronic Anal Fissure

RecruitingPhase 4NCT03855046
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

This study is aimed at studying the efficacy and safety of treating chronic anal fissure with botulinum toxin versus lateral subcutaneous sphincterotomy.

Study details

Official title
A Comparative Efficacy and Safety Study of Lateral Subcutaneous Sphincterotomy and Botulinum Toxin Type A in the Treatment of Chronic Anal Fissure
Conditions
  • Fissure in Ano
Interventions
  • Drug: IncobotulinumtoxinA 50 U Intramuscular Powder for Solution
  • Procedure: Lateral subcutaneous sphincterotomy.
Sponsor
State Scientific Centre of Coloproctology, Russian Federation
Collaborators
St. Petersburg State Pavlov Medical University; Astrakhan State Medical University; Siberian State Medical University; City Clinical Hospital №24, Department of Health City of Moscow; GBUZ MO "Lvovskaia Raionaia Bolnica"; Medical Center ON-CLINIC
Start date
2019-09-01
Primary completion
2022-09-01
Sex
All
Age range
from 18 Years to 70 Years
Results posted
No results posted in this snapshot
Countries
Russia
Total sites listed
7

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patients with chronic anal fissure Exclusion Criteria: * Inflammatory diseases of the colon * Pectenosis * Previous surgical interventions on the anal canal * IV grade internal and external hemorrhoids * Rectal fistula * Severe somatic diseases at the decompensation stage * Pregnancy and lactation * Individual intolerance and hypersensitivity to botulinum toxin * Myasthenia gravis and myasthenia-like syndromes * Anal sphincter insufficiency

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03855046